iodine has been researched along with Carcinoma, Neuroendocrine in 4 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Carcinoma, Neuroendocrine: A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round blue cells, granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small (oat) cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prevalence and pathology pattern of iodine deficiency (ID) related disorders are influenced by the dietary iodine intake: low iodine leads to thyroid nodular enlargement, to an increase in the incidence of thyroid cancer, an increase in anaplastic carcinomas and to an alteration in the papillary to follicular neoplasia ratio." | 3.81 | Iodine deficiency and thyroid nodular pathology--epidemiological and cancer characteristics in different populations: Portugal and South Africa. ( Castelo Branco, M; Freitas, M; Kalk, WJ; Marques Carreira, I; Santos, JE, 2015) |
| "Anaplastic thyroid carcinoma is almost uniformly lethal, and iodine-131 imaging and radioactive iodine cannot be used." | 1.72 | Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. ( Ball, D; Bernet, V; Bischoff, L; Blomain, E; Busaidy, NL; Campbell, M; Cassara, CJ; Darlow, S; Dickson, P; Duh, QY; Ehya, H; Goldner, WS; Guo, T; Haddad, RI; Haymart, M; Holt, S; Hunt, JP; Iagaru, A; Kandeel, F; Lamonica, DM; Mandel, S; Markovina, S; McIver, B; Raeburn, CD; Rezaee, R; Ridge, JA; Roth, MY; Scheri, RP; Shah, JP; Sipos, JA; Sippel, R; Sturgeon, C; Wang, TN; Wirth, LJ; Wong, RJ; Yeh, M, 2022) |
| "Recently, the main therapy of medullary thyroid cancer (MTC) is surgical, but by which way there is a poor prognosis with a mean survival of only 5 years." | 1.40 | All-trans-retinoic acid promotes iodine uptake via up- regulating the sodium iodide symporter in medullary thyroid cancer stem cells. ( Chen, XY; Duan, LQ; Hou, YL; Hu, XL; Kang, QQ; Li, SL; Peng, ZP; Shu, J; Tang, M, 2014) |
| "We examined thyroid cancer incidence patterns using data from the Sao Paulo Cancer Registry (SPCR) in Brazil and the National Cancer Institute's Surveillance Epidemiology End Results (SEER) program in the United States." | 1.39 | Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008. ( Aschebrook-Kilfoy, B; Devesa, SS; Neta, G; Ron, E; Veiga, LH, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haddad, RI | 1 |
| Bischoff, L | 1 |
| Ball, D | 1 |
| Bernet, V | 1 |
| Blomain, E | 1 |
| Busaidy, NL | 1 |
| Campbell, M | 1 |
| Dickson, P | 1 |
| Duh, QY | 1 |
| Ehya, H | 1 |
| Goldner, WS | 1 |
| Guo, T | 1 |
| Haymart, M | 1 |
| Holt, S | 1 |
| Hunt, JP | 1 |
| Iagaru, A | 1 |
| Kandeel, F | 1 |
| Lamonica, DM | 1 |
| Mandel, S | 1 |
| Markovina, S | 1 |
| McIver, B | 1 |
| Raeburn, CD | 1 |
| Rezaee, R | 1 |
| Ridge, JA | 1 |
| Roth, MY | 1 |
| Scheri, RP | 1 |
| Shah, JP | 1 |
| Sipos, JA | 1 |
| Sippel, R | 1 |
| Sturgeon, C | 1 |
| Wang, TN | 1 |
| Wirth, LJ | 1 |
| Wong, RJ | 1 |
| Yeh, M | 1 |
| Cassara, CJ | 1 |
| Darlow, S | 1 |
| Veiga, LH | 1 |
| Neta, G | 1 |
| Aschebrook-Kilfoy, B | 1 |
| Ron, E | 1 |
| Devesa, SS | 1 |
| Tang, M | 1 |
| Hou, YL | 1 |
| Kang, QQ | 1 |
| Chen, XY | 1 |
| Duan, LQ | 1 |
| Shu, J | 1 |
| Li, SL | 1 |
| Hu, XL | 1 |
| Peng, ZP | 1 |
| Santos, JE | 1 |
| Kalk, WJ | 1 |
| Freitas, M | 1 |
| Marques Carreira, I | 1 |
| Castelo Branco, M | 1 |
4 other studies available for iodine and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Topics: Adenocarcinoma; Carcinoma, Neuroendocrine; Humans; Iodine; Iodine Radioisotopes; Thyroid Carcinoma, | 2022 |
Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.
Topics: Adenocarcinoma, Follicular; Age Factors; Brazil; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Pa | 2013 |
All-trans-retinoic acid promotes iodine uptake via up- regulating the sodium iodide symporter in medullary thyroid cancer stem cells.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding | 2014 |
Iodine deficiency and thyroid nodular pathology--epidemiological and cancer characteristics in different populations: Portugal and South Africa.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Carcinoma; Carcinoma, Medullary; Carcinoma, Neu | 2015 |